Invention Grant
- Patent Title: Glucose-sensitive albumin-binding derivatives
-
Application No.: US17500242Application Date: 2021-10-13
-
Publication No.: US11767332B2Publication Date: 2023-09-26
- Inventor: Thomas Kruse , Mikael Kofod-Hansen , Martin Werner Borchsenius Muenzel , Henning Thoegersen , Per Sauerberg , Jakob Ewald Rasmussen , Carsten Behrens , Thomas Hoeg-Jensen , Vojtech Balsanek , Zuzana Drobnakova , Ladislav Droz , Miroslav Havranek , Vladislav Kotek , Milan Stengl , Ivan Snajdr , Hana Drusanova
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Jianjie Hu
- Priority: EP 200734 2017.11.09 EP 178294 2018.06.18
- Main IPC: C07F5/02
- IPC: C07F5/02 ; A61K47/54
Abstract:
This invention relates to glucose-sensitive albumin-binding diboron conjugates. More particularly the invention provides novel diboron compounds, and in particular diboronate or diboroxole compounds, useful as intermediate compounds for the synthesis of diboron conjugates.
Public/Granted literature
- US20220081451A1 GLUCOSE-SENSITIVE ALBUMIN-BINDING DERIVATIVES Public/Granted day:2022-03-17
Information query
